Study to Investigate the Irritation Potential of GSK1940029 Gel

NCT01984801 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline